Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Tag: $TLSA

May 24, 2026

FREE BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 05-24-2026 TO 05-30-2026

I’m excited to announce the release of my latest free bio tech stock catalyst report for the upcoming week. This new free stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock…

FREE Weekly Stock Catalyst Report

$CRBP, $CRDF, $FATE, $SNDX, $TLSA, 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, 7th World Parkinson Congress, biopharmaceutical, clinical-research, fda, new drug application, pr-newswire, press-releases, TD Cowen Annual Oncology Innovation Summit: Insights for ASCO & EHA
January 20, 2026

Groundbreaking Clinical Results for Intranasal Foralumab Published by Tiziana Life Sciences

NASDAQ: $TLSA Tiziana Life Sciences plc recently announced a significant milestone in their ongoing research and development efforts: the peer-reviewed publication of clinical study results concerning their lead product candidate, intranasal Foralumab. This publication, detailed in a press release issued on January 20, 2026, marks a crucial step forward in validating the potential of this…

Clinical Trial

$TLSA, Clinical Study Results, Foralumab, Immunomodulation, Intranasal Therapy, Tiziana Life Sciences

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Get FREE Biotech Stock Catalyst Reports

Email

Notify me about related content and special offers.

Yes No

If you opt in above, we use this information to send related content, discounts, and other special offers.